Rankings
▼
Calendar
CRMD Q4 2019 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$518M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$24,779
-6.6% YoY
Gross Profit
-$21,346
-86.1% margin
Operating Income
-$5M
-21698.1% margin
Net Income
-$5M
-21409.0% margin
EPS (Diluted)
$-0.21
QoQ Revenue Growth
-58.4%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$453,344
Balance Sheet
Total Assets
$29M
Total Liabilities
$6M
Stockholders' Equity
-$195M
Cash & Equivalents
$17M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24,779
$26,523
-6.6%
Gross Profit
-$21,346
$4,410
-584.0%
Operating Income
-$5M
$2M
-351.5%
Net Income
-$5M
$2M
-346.9%
← FY 2019
All Quarters
Q1 2020 →